Drug profile · INN
warfarin
COUMADIN
warfarin (COUMADIN) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Associated with Viatris Pharmaceuticals Co.,.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 12
News articles 0
Drug details — warfarin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 12
- Data quality
- 0.81
Quick answer
warfarin (COUMADIN) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Associated with Viatris Pharmaceuticals Co.,.
Key facts
INN warfarin
Brand COUMADIN
Mechanism Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
Originator Viatris Pharmaceuticals Co.,
Mechanism of action
Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is warfarin?
warfarin (COUMADIN) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Associated with Viatris Pharmaceuticals Co.,.
What is the brand name for warfarin?
COUMADIN is a marketed brand name for warfarin. Check FDA Drugs@FDA for the current US label holder and prescribing information.